Veterinary Therapeutics Market Report 2021-2031: Visiongain ...| MENAFN.COM

Friday, 07 October 2022 06:20 GMT

Veterinary Therapeutics Market Report 2021-2031: Visiongain Research Inc.

(MENAFN- GlobeNewsWire - Nasdaq)

Visiongain has published a new report on Veterinary Therapeutics Market Report From 2021-2031: Forecasts By Product Type (Drugs, Vaccines, and Medicated Feed Additives), By Animal (Companion Animal, and Livestock Animal), By Route of Administration (Oral, Parenteral, and Topical), By End User (Veterinary Hospital, Veterinary Specialty Clinics, Research Institutes and Universities, and Others), By Distribution Channel (Retail Pharmacies, Veterinary Hospital Pharmacies, and Online Pharmacies), PLUS Profiles of Leading Manufacturing Companies and Regional and Leading National Market Analysis. PLUS, COVID-19 Recovery Scenarios .

COVID-19 Impact on Veterinary Therapeutics

COVID-19 impact through different recovery models such as V-shaped, U-shaped, W-shaped, and L-shaped; has been taken into consideration while estimating and forecasting the Veterinary Therapeutics. Different recovery scenarios are also included in the report for all the segments and regions/nation. The recovery scenarios based on which market has been forecasted and analyzed herein the report are mentioned below:

Download Exclusive Sample of Report @

Market Drivers

Growth in the Companion Animal Population
There is a very fast rapid increase in companion animal population around the world as usage of animals as human companions has taken new heightened importance and rising numbers of families preferring to have pets. Companion animals are at high risk of developing various diseases for which companion animals require timely treatment for life-causing diseases. Continuous increase in the number of companion animals around the world is also increasing demand for companion animal diagnostics around the world. Due to which growth in the companion animal population around the world is working as a driver for the veterinary therapeutics market.

Increase usage of Veterinary Therapeutics for Zoonotic Diseases
Demand for veterinary therapeutics for zoonotic diseases is increasing due to the increasing prevalence of life-causing diseases such as zoonotic diseases in companion animals. Increasing prevalence of life-causing diseases in companion animals has led various veterinary hospitals and clinics, point-of-care centres, and research institutes and universities to use veterinary therapeutics for zoonotic disease treatment to increase chances of saving companion animals. Due to which growth in the companion animal population around the world is working as a driver for the veterinary therapeutics market.

Market Opportunities

Increasing initiative and awareness program
Various national and international organizations, regulatory authorities, independent authority, non-profit organizations are launching various awareness programs to increase awareness regarding awareness for zoonotic diseases. Increasing awareness for zoonotic diseases is expected to increase the diagnosis and treatment rate which will increase demand of veterinary therapeutics for zoonotic diseases treatment in the forecasted period.

Increasing Advanced therapeutics for development of new vaccines for an array of diseases
Demand of advanced therapeutics in the companion animal treatment is increasing as compared to previous years. Various veterinary hospitals and clinics, point-of-care and research institutes and universities are using more and more advanced therapeutics for treatment of companion animal treatment. Currently, many of the manufacturers are engaged in research and development activities creating competitive advantages with the launch of their new products in the market.

Get Detailed TOC @

How the Veterinary Therapeutics Market report helps you
In summary, our 250+ page report provides you with the following knowledge:

  • Revenue forecasts to 2031 for Veterinary Therapeutics Market, with forecasts for Get our report today Veterinary Therapeutics Market Forecast 2021-2031: By Product, Animal, Route of Administration, End User, Distribution Channel and Leading Regional/ Country market analysis each forecasted at a global and regional level– discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Veterinary Therapeutics market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Veterinary Therapeutics Market .

Competitive Landscape

Top companies (Zoetis, Inc., Merck Animal Health, Elanco Animal Health, and Boehringer Ingelheim GmbH) constitute more than XX% share of the global Veterinary Therapeutics. Other companies profiled in the report include: Ceva Santé Animale, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Biovac, The Chanelle Group and ImmuCell Corporation.

Some of the key developments are listed below:

In 2018, The World Small Animal Veterinary Association (WSAVA) has launched campaigns in order to secure veterinary therapeutics access for veterinarians. The WSAVA is forming a Therapeutics Guidelines Group (TGG) in order to improvise access to veterinary therapeutics. These campaigns are expected to create to new growth opportunities for the market

In 2018, Akaal Pharma Pty Ltd, and Bal Pharma Ltd, collaborated to form Joint Venture Company 'AB VET Pharma Pty Ltd'. The new joint venture will be providing therapeutics within the veterinary field. With new joint ventures Akaal Pharma Pty Ltd, and Bal Pharma Ltd is expected to increase their market share in the veterinary therapeutics market.

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email 

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Veterinary Therapeutics Market and leading companies . Here you will find data, trends and predictions. Please order our report now.

Find more Visiongain research reports on Therapeutic Drugs Sector click on the following links:

  • Acetaminophen (Paracetamol) Market
  • Respiratory Drug Delivery Market
  • Vaccine Drug Delivery Market
  • Retinal Disorder Treatment Market

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: 

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.


Sara Peerun
Commercial Director
Visiongain Inc.
Tel: + 44 207 549 9987
USA Tel: 00 1 718 682 4567
EU Tel: 00 353 1 695 0006
Follow Us: LinkedIn | Twitter


SOURCE Visiongain Limited.

Tags Veterinary Therapeutics Market Companion Animal Population Demand for veterinary global pharma market Animal pharma market


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.